Snowball logo
logo
RDY_logo

Dr. Reddys Laboratories Limited

$13.31+$0.05  (0.38%)

Frequently asked questions

What sector does Dr. Reddys Laboratories Limited (RDY) operate in?

Dr. Reddys Laboratories Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Dr. Reddys Laboratories Limited (RDY) current stock price?

As of the latest data, Dr. Reddys Laboratories Limited stock price is $13.31, with a previous close of $13.26. Dr. Reddys Laboratories Limited gained $0.05 in the last trading session, representing a 0.38% increase.

What is Dr. Reddys Laboratories Limited (RDY) current market capitalization?

Dr. Reddys Laboratories Limited market cap is approximately 11.08 billion.

What is Dr. Reddys Laboratories Limited (RDY) Earnings Per Share (EPS)?

The trailing EPS is $0.73, and the forward EPS is $51.82.

What is Dr. Reddys Laboratories Limited (RDY) Price-to-Earnings (P/E) ratio?

Dr. Reddys Laboratories Limited current P/E ratio is 18.23, with a forward P/E of 0.26.

What is Dr. Reddys Laboratories Limited (RDY) EBITDA?

Dr. Reddys Laboratories Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 19.56 billion.

Does Dr. Reddys Laboratories Limited (RDY) pay dividends?

Yes. Dr. Reddys Laboratories Limited pays annual dividends with an annualized yield of 0.69% and an estimated annual payout of $0.09 per share.

When is the next ex-dividend date for Dr. Reddys Laboratories Limited (RDY)?

The next ex-dividend date is scheduled for July 25, 2026.

How did Dr. Reddys Laboratories Limited (RDY) perform in its most recent earnings report?

In the last report (December 31, 2025), Dr. Reddys Laboratories Limited posted an EPS surprise of 1.94% and a revenue surprise of 3.25%.

When is Dr. Reddys Laboratories Limited (RDY) next earnings report?

Dr. Reddys Laboratories Limited is expected to release its next earnings report on March 31, 2026.

What is Dr. Reddys Laboratories Limited (RDY) beta (volatility) score?

Dr. Reddys Laboratories Limited has a beta of 0.302, indicating lower volatility than the overall market.